Logo image of BZUN

BAOZUN INC-SPN ADR (BZUN) Stock Fundamental Analysis

NASDAQ:BZUN - Nasdaq - US06684L1035 - ADR - Currency: USD

2.63  -0.02 (-0.75%)

Fundamental Rating

3

Taking everything into account, BZUN scores 3 out of 10 in our fundamental rating. BZUN was compared to 28 industry peers in the Broadline Retail industry. BZUN may be in some trouble as it scores bad on both profitability and health. BZUN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BZUN had negative earnings in the past year.
In the past 5 years BZUN reported 4 times negative net income.
Of the past 5 years BZUN 4 years had a positive operating cash flow.
BZUN Yearly Net Income VS EBIT VS OCF VS FCFBZUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

The Return On Assets of BZUN (-1.87%) is comparable to the rest of the industry.
BZUN has a Return On Equity (-4.74%) which is in line with its industry peers.
Industry RankSector Rank
ROA -1.87%
ROE -4.74%
ROIC N/A
ROA(3y)-3.64%
ROA(5y)-1.73%
ROE(3y)-9.17%
ROE(5y)-5.01%
ROIC(3y)N/A
ROIC(5y)N/A
BZUN Yearly ROA, ROE, ROICBZUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

Looking at the Gross Margin, with a value of 73.34%, BZUN belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
In the last couple of years the Gross Margin of BZUN has grown nicely.
BZUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y3.57%
BZUN Yearly Profit, Operating, Gross MarginsBZUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

BZUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BZUN has been reduced compared to 1 year ago.
The number of shares outstanding for BZUN has been reduced compared to 5 years ago.
Compared to 1 year ago, BZUN has a worse debt to assets ratio.
BZUN Yearly Shares OutstandingBZUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BZUN Yearly Total Debt VS Total AssetsBZUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BZUN has an Altman-Z score of 1.35. This is a bad value and indicates that BZUN is not financially healthy and even has some risk of bankruptcy.
BZUN has a Altman-Z score of 1.35. This is in the lower half of the industry: BZUN underperforms 64.29% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that BZUN is not too dependend on debt financing.
BZUN has a Debt to Equity ratio of 0.42. This is in the lower half of the industry: BZUN underperforms 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 1.35
ROIC/WACCN/A
WACC2.4%
BZUN Yearly LT Debt VS Equity VS FCFBZUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.99 indicates that BZUN should not have too much problems paying its short term obligations.
BZUN's Current ratio of 1.99 is fine compared to the rest of the industry. BZUN outperforms 67.86% of its industry peers.
BZUN has a Quick Ratio of 1.65. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
BZUN has a better Quick ratio (1.65) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.65
BZUN Yearly Current Assets VS Current LiabilitesBZUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

3

3. Growth

3.1 Past

BZUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.54%.
BZUN shows a small growth in Revenue. In the last year, the Revenue has grown by 6.76%.
BZUN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.30% yearly.
EPS 1Y (TTM)-28.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-288.24%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y0.09%
Revenue growth 5Y5.3%
Sales Q2Q%4.27%

3.2 Future

BZUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 80.20% yearly.
Based on estimates for the next years, BZUN will show a small growth in Revenue. The Revenue will grow by 4.43% on average per year.
EPS Next Y320.62%
EPS Next 2Y130.61%
EPS Next 3Y108.16%
EPS Next 5Y80.2%
Revenue Next Year4.5%
Revenue Next 2Y3.98%
Revenue Next 3Y4.54%
Revenue Next 5Y4.43%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BZUN Yearly Revenue VS EstimatesBZUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
BZUN Yearly EPS VS EstimatesBZUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6 8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BZUN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 7.96, which indicates a rather cheap valuation of BZUN.
BZUN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BZUN is cheaper than 85.71% of the companies in the same industry.
BZUN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 33.87.
Industry RankSector Rank
PE N/A
Fwd PE 7.96
BZUN Price Earnings VS Forward Price EarningsBZUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BZUN is valued a bit cheaper than the industry average as 64.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.19
BZUN Per share dataBZUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

BZUN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BZUN's earnings are expected to grow with 108.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y130.61%
EPS Next 3Y108.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BZUN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAOZUN INC-SPN ADR

NASDAQ:BZUN (8/11/2025, 8:19:43 PM)

2.63

-0.02 (-0.75%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-21 2025-08-21
Inst Owners19.92%
Inst Owner Change-1.51%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap151.97M
Analysts83.33
Price Target3.81 (44.87%)
Short Float %4.72%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.04%
Min EPS beat(2)31.65%
Max EPS beat(2)42.43%
EPS beat(4)2
Avg EPS beat(4)-97.01%
Min EPS beat(4)-346.95%
Max EPS beat(4)42.43%
EPS beat(8)4
Avg EPS beat(8)-168.99%
EPS beat(12)4
Avg EPS beat(12)-228.99%
EPS beat(16)6
Avg EPS beat(16)-261.31%
Revenue beat(2)1
Avg Revenue beat(2)0%
Min Revenue beat(2)-0.42%
Max Revenue beat(2)0.42%
Revenue beat(4)2
Avg Revenue beat(4)2.16%
Min Revenue beat(4)-4.21%
Max Revenue beat(4)12.85%
Revenue beat(8)3
Avg Revenue beat(8)-0.24%
Revenue beat(12)3
Avg Revenue beat(12)-1.21%
Revenue beat(16)4
Avg Revenue beat(16)-1.68%
PT rev (1m)0%
PT rev (3m)2.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-38.81%
EPS NY rev (1m)0%
EPS NY rev (3m)95.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.96
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB 0.35
EV/EBITDA 10.19
EPS(TTM)-0.2
EYN/A
EPS(NY)0.33
Fwd EY12.56%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS22.9
BVpS9.25
TBVpS7.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.87%
ROE -4.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.34%
FCFM N/A
ROA(3y)-3.64%
ROA(5y)-1.73%
ROE(3y)-9.17%
ROE(5y)-5.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y3.57%
F-ScoreN/A
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA 14.94
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.65
Altman-Z 1.35
F-ScoreN/A
WACC2.4%
ROIC/WACCN/A
Cap/Depr(3y)102.69%
Cap/Depr(5y)116.63%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-288.24%
EPS Next Y320.62%
EPS Next 2Y130.61%
EPS Next 3Y108.16%
EPS Next 5Y80.2%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y0.09%
Revenue growth 5Y5.3%
Sales Q2Q%4.27%
Revenue Next Year4.5%
Revenue Next 2Y3.98%
Revenue Next 3Y4.54%
Revenue Next 5Y4.43%
EBIT growth 1Y26.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year371.87%
EBIT Next 3Y81.92%
EBIT Next 5Y55.39%
FCF growth 1Y-149.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-77.46%
OCF growth 3YN/A
OCF growth 5Y-19.64%